Sirona Dental Systems Inc

Sirona Dental Systems — Q4 2015 Earnings Presentation

23 slides from Sirona Dental Systems's earnings presentation, Nov 20, 2015

  1. Slide 1: Sirona – The Dental Company Fourth Quarter 2015 Earnings Presentation

    Sirona – The Dental Company Fourth Quarter 2015 Earnings Presentation November 20, 2015

  2. Slide 2: Safe Harbor Statement / Additional Information – Forward-Looking Statements

    Page 2 Fourth Quarter 2015 Earnings Presentation Safe Harbor Statement / Additional Information PP. Forward - Looking Statements This communication, in addition to historical information, contains “forward - looking statements” (as defined in the Securities Litigation Reform Act of 1995) regarding,

  3. Slide 3: Safe Harbor Statement / Additional Information

    Page 3 Fourth Quarter 2015 Earnings Presentation Safe Harbor Statement / Additional Information PP. Additional information concerning other risk factors is also contained in DENTSPLY’s and Sirona’s most recently filed Annual Re ports on Form 10 - K, subsequent Quarterly Reports on Form 10 - Q, Curre

  4. Slide 4: Additional Information And Where To Find It

    Page 4 Fourth Quarter 2015 Earnings Presentation Safe Harbor Statement / Additional Information PP. Additional Information And Where To Find It This communication is for informational purposes only and does not constitute an offer to sell or the solicitation of an offe r to buy any securities or a s

  5. Slide 5: Fiscal Year 2015 Performance Summary

    Page 5 Fiscal Year 2015 Performance Summary ■ FY15 revenue growth of 9.8% on a local currency basis and 8.8% on a local currency basis excluding acquisitions ■ Instruments up 14.1% local currency ■ CAD/CAM up 12.1% local currency (up 9.4% excluding acquisitions) ■ Treatment Centers up 11.8% local cu

  6. Slide 6: Fiscal Year 2015 Performance Summary

    Page 6 Fiscal Year 2015 Performance Summary ■ FY15 Strong local currency growth led by international markets ■ International markets grew 10.0% local currency ■ U.S. revenues grew 9.2% (6.0% excluding acquisitions) ■ Non - GAAP adjusted EPS of $3.98, representing 8.4% EPS growth ■ Free Cash Flow (ex

  7. Slide 7: Fourth Quarter 2015 Performance Summary

    Page 7 Fourth Quarter 2015 Performance Summary ■ 4Q15 local currency revenue growth of 18.0% (14.1% organic) with: ■ Instruments up 35.1% local currency ■ CAD/CAM up 23.2% local currency (12.2% excluding acquisitions) ■ Imaging up 11.5% local currency ■ Treatment Centers up 11.7% local currency ■ Re

  8. Slide 8: Overview

    Page 8 Fourth Quarter 2015 Earnings Presentation Overview Revenue (US$ in millions) ■ Revenues of $304.9 million, up 18.0% local currency. ■ International revenues were up 12.6% on a local currency basis . Growth was driven by strength in Europe as well as tender business in the Middle East. ■ Reven

  9. Slide 9: CAD/CAM Segment

    Page 9 Fourth Quarter 2015 Earnings Presentation CAD/CAM Segment CAD/CAM Revenue (US$ in millions) Segment Gross Profit (US$ in millions) Revenue Growth Local Currency Growth + 23.2% FX Impact - 12.1% GAAP Revenue Change 11.1% Segment Gross Profit Margin 4Q14 68.2% 4Q15 70.2% Change +200 bps

  10. Slide 10: CAD/CAM Segment

    Page 10 Fourth Quarter 2015 Earnings Presentation CAD/CAM Segment ■ Revenues of $113.2 million, up 23.2% local currency. ■ Excluding acquisitions, revenues were up 12.2% local currency. ■ Growth was driven by strength in the U.S. and Asia - Pacific with solid new user sales for both our chairside an

  11. Slide 11: Imaging Segment

    Page 11 Fourth Quarter 2015 Earnings Presentation Imaging Segment Imaging Revenue (US$ in millions) Segment Gross Profit Margin 4Q14 57.3% 4Q15 56.2%* Change - 110 bps Segment Gross Profit (US$ in millions) Revenue Growth Local Currency Growth + 11.5% FX Impact - 9.3% GAAP Revenue Change + 2.2% * Ex

  12. Slide 12: Imaging Segment

    Page 12 Fourth Quarter 2015 Earnings Presentation Imaging Segment ■ Revenues of $99.1 million, up 11.5% on a local currency basis. ■ Revenue growth was driven by strong demand for our 3D products. The Orthophos SL 2D - 3D is off to a good start. ■ Gross profit margin decreased 110 basis points to 56

  13. Slide 13: Treatment Centers

    Page 13 Fourth Quarter 2015 Earnings Presentation Treatment Centers Treatment Center Revenue (US$ in millions) Segment Gross Profit Margin 4Q14 43.1% 4Q15 39.3% Change - 380 bps Segment Gross Profit (US$ in millions) Revenue Growth Local Currency Growth + 11.7% FX Impact - 16.5% GAAP Reported Change

  14. Slide 14: Treatment Centers

    Page 14 Fourth Quarter 2015 Earnings Presentation Treatment Centers ■ Revenues of $59.6 million, up 11.7% in local currency. ■ Strong growth in non - European international markets benefited from tender business. The U.S. started to contribute to growth with the successful launch of Treatment Center

  15. Slide 15: Instruments

    Page 15 Fourth Quarter 2015 Earnings Presentation Instruments Instruments Revenue (US$ in millions) Revenue Growth Local Currency Growth + 35.1% FX Impact - 19.2% GAAP Reported Change + 15.9% Segment Gross Profit Margin 4Q14 47.4% 4Q15 44.8% Change - 260 bps Segment Gross Profit (US$ in millions)

  16. Slide 16: Instruments

    Page 16 Fourth Quarter 2015 Earnings Presentation Instruments ■ Record revenues of $33.0, up 35.1% in local currency. ■ Revenue growth was driven by strength in handpieces and hygiene benefiting from very strong tender business and continued growth in Germany. ■ Segment gross profit margin decreased

  17. Slide 17: Operating Performance

    Page 17 4Q15 4Q14 % chg. Revenue $ 304.9 $ 290.0 5% Cost of sales 138.0 130.1 6% Gross profit 166.9 159.9 4% Gross Margin % 54.7% 55.1% Selling, general and administrative expense 90.2 87.6 3% Research and development 12.9 16.5 (22)% Other operating income items (net) (1.3) (2.5) Operating income 65

  18. Slide 18: Conclusion

    Page 18 Fourth Quarter 2015 Earnings Presentation Conclusion ■ Strong progress on all of our strategic objectives ■ Record number of innovations introduced at IDS ■ Orthophos SL – 2D/3D Extraoral Imaging family ■ TENEO 2015 – Premium segment Treatment Center ■ Omnicam AF (Acquisition Flex) and Omnic

  19. Slide 19: Conclusion

    Page 19 Fourth Quarter 2015 Earnings Presentation Conclusion ■ With CEREC 30, we created the largest digital dentistry event in the world ■ Successfully launched Treatment Centers to the U.S. market ■ Introduced consumer marketing services and SIROWORLD ■ Continued investment in our sales and servic

  20. Slide 20: Conclusion

    Page 20 Fourth Quarter 2015 Earnings Presentation Conclusion ■ Announced transformational merger with DENTSPLY creating THE Dental Solutions Company ■ Filed preliminary merger proxy for special shareholder meeting ■ In the process of submitting all necessary filings as required by various regulatory

  21. Slide 21: Reconciliation of GAAP EPS to Q4 2015 Non-GAAP Adjusted EPS

    Page 21 Reconciliation of GAAP EPS to Q4 2015 Non - GAAP Adjusted EPS Pre Tax Tax Impact* After Tax Per Diluted Share $ 45.4 $ 0.80 Adjustments Amortization and depreciation expense resulting from the step-up to fair values of intangible assets related to past business combinations $ 6.3 $ 1.3 5.0 (

  22. Slide 22: Reconciliation of GAAP EPS to FY 2015 Non-GAAP Adjusted EPS

    Page 22 Reconciliation of GAAP EPS to FY 2015 Non - GAAP Adjusted EPS Pre Tax Tax Impact* After Tax Per Diluted Share $ 186.2 $ 3.30 Adjustments Amortization and depreciation expense resulting from the step- up to fair values of intangible assets related to past business combinations $ 26.3 $ 5.9 20

  23. Slide 23: Non-GAAP Measures Disclosure

    Page 23 Non - GAAP Measures Disclosure To supplement our consolidated financial statements and our business outlook, we use the following non - GAAP financial measures: (i) non - GAAP adjusted net income, and (ii) non - GAAP adjusted earnings per diluted share, which exclude, as applicable, amortiza

Sirona Dental Systems — Q4 2015 Earnings Presentation on 6ix